Global Tuberculosis (TB) Diagnostics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
According to our (Global Info Research) latest study, the global Tuberculosis (TB) Diagnostics market size was valued at USD 2706.1 million in 2022 and is forecast to a readjusted size of USD 3635.2 million by 2029 with a CAGR of 4.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%.
APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent. 
In terms of product, Culture-based is the largest segment, with a share about 33%. And in terms of application, the largest application is Hospitals, followed by Diagnostic Laboratories.
This report is a detailed and comprehensive analysis for global Tuberculosis (TB) Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Tuberculosis (TB) Diagnostics market size and forecasts, in consumption value ($ Million), 2018-2029
Global Tuberculosis (TB) Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Tuberculosis (TB) Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Tuberculosis (TB) Diagnostics market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Tuberculosis (TB) Diagnostics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Tuberculosis (TB) Diagnostics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Danaher, Roche, Thermo Fisher Scientific, BD and Abbott, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Tuberculosis (TB) Diagnostics market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    Culture-Based Diagnostics
    Sputum Smear Microscopy
    Rapid Molecular Diagnostics
    Others
Market segment by Application
    Diagnostic Laboratories
    Hospitals
Market segment by players, this report covers
    Danaher
    Roche
    Thermo Fisher Scientific
    BD
    Abbott
    Hologic
    Qiagen
    BioMerieux
    Hain Lifescience
    Oxford Immunotec
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Tuberculosis (TB) Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Tuberculosis (TB) Diagnostics, with revenue, gross margin and global market share of Tuberculosis (TB) Diagnostics from 2018 to 2023.
Chapter 3, the Tuberculosis (TB) Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Tuberculosis (TB) Diagnostics market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Tuberculosis (TB) Diagnostics.
Chapter 13, to describe Tuberculosis (TB) Diagnostics research findings and conclusion.